Axios Pro Exclusive Content

Novo targets monthly obesity dosing with $1.3B Nanexa deal

Sep 25, 2026
Illustration of semaglutide injector pens forming the dollar sign symbol.

Illustration: Shoshana Gordon/Axios

What to read next